메뉴 건너뛰기




Volumn 97, Issue 7, 2012, Pages 1110-1114

CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype

Author keywords

CD20; Cell lines; Multiple myeloma; Phenotype; Stem cell

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; SYNDECAN 1;

EID: 84863886613     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.057372     Document Type: Article
Times cited : (30)

References (24)
  • 1
    • 80052345517 scopus 로고    scopus 로고
    • Can multiple myeloma become a curable disease?
    • San-Miguel JF, Mateos MV. Can multiple myeloma become a curable disease? Haematologica. 2011;96(9):1246-8.
    • (2011) Haematologica , vol.96 , Issue.9 , pp. 1246-1248
    • San-Miguel, J.F.1    Mateos, M.V.2
  • 2
    • 0033977906 scopus 로고    scopus 로고
    • In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease
    • Pilarski LM, Giannakopoulos NV, Szczepek AJ, Masellis AM, Mant MJ, Belch AR. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease. Clin Cancer Res. 2000;6(2):585-96.
    • (2000) Clin Cancer Res , vol.6 , Issue.2 , pp. 585-596
    • Pilarski, L.M.1    Giannakopoulos, N.V.2    Szczepek, A.J.3    Masellis, A.M.4    Mant, M.J.5    Belch, A.R.6
  • 4
    • 20444400843 scopus 로고    scopus 로고
    • Phenotypic characterization of the human myeloma cell growth fraction
    • Robillard N, Pellat-Deceunynck C, Bataille R. Phenotypic characterization of the human myeloma cell growth fraction. Blood. 2005;105(12):4845-8.
    • (2005) Blood , vol.105 , Issue.12 , pp. 4845-4848
    • Robillard, N.1    Pellat-Deceunynck, C.2    Bataille, R.3
  • 5
    • 8844264524 scopus 로고    scopus 로고
    • The SCID-rab model: A novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
    • Yata K, Yaccoby S. The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia. 2004;18(11):1891-7.
    • (2004) Leukemia , vol.18 , Issue.11 , pp. 1891-1897
    • Yata, K.1    Yaccoby, S.2
  • 6
    • 38549132452 scopus 로고    scopus 로고
    • Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance
    • Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 2008; 68(1):190-7.
    • (2008) Cancer Res , vol.68 , Issue.1 , pp. 190-197
    • Matsui, W.1    Wang, Q.2    Barber, J.P.3    Brennan, S.4    Smith, B.D.5    Borrello, I.6
  • 7
    • 1442331704 scopus 로고    scopus 로고
    • Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency
    • Lim SH, Zhang Y, Wang Z, Varadarajan R, Periman P, Esler WV. Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency. Blood. 2004;103(5):1971-2.
    • (2004) Blood , vol.103 , Issue.5 , pp. 1971-1972
    • Lim, S.H.1    Zhang, Y.2    Wang, Z.3    Varadarajan, R.4    Periman, P.5    Esler, W.V.6
  • 8
    • 0344553476 scopus 로고    scopus 로고
    • Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation
    • Musto P, Carella AM Jr, Greco MM, Falcone A, Sanpaolo G, Bodenizza C, et al. Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation. Br J Haematol. 2003;123(4):746-7.
    • (2003) Br J Haematol , vol.123 , Issue.4 , pp. 746-747
    • Musto, P.1    Carella Jr., A.M.2    Greco, M.M.3    Falcone, A.4    Sanpaolo, G.5    Bodenizza, C.6
  • 9
    • 79960262937 scopus 로고    scopus 로고
    • Evaluating the clonal hierarchy in light-chain multiple myeloma: Implications against the myeloma stem cell hypothesis
    • Pfeifer S, Perez-Andres M, Ludwig H, Sahota SS, Zojer N. Evaluating the clonal hierarchy in light-chain multiple myeloma: implications against the myeloma stem cell hypothesis. Leukemia. 2011;25(7):1213-6.
    • (2011) Leukemia , vol.25 , Issue.7 , pp. 1213-1216
    • Pfeifer, S.1    Perez-Andres, M.2    Ludwig, H.3    Sahota, S.S.4    Zojer, N.5
  • 10
    • 77957761400 scopus 로고    scopus 로고
    • Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma
    • Rasmussen T, Haaber J, Dahl IM, Knudsen LM, Kerndrup GB, Lodahl M, et al. Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma. Haematologica. 2010;95(10):1730-7.
    • (2010) Haematologica , vol.95 , Issue.10 , pp. 1730-1737
    • Rasmussen, T.1    Haaber, J.2    Dahl, I.M.3    Knudsen, L.M.4    Kerndrup, G.B.5    Lodahl, M.6
  • 11
    • 65549099309 scopus 로고    scopus 로고
    • Zalypsis: A novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks
    • Ocio EM, Maiso P, Chen X, Garayoa M, Alvarez-Fernandez S, San-Segundo L, et al. Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks. Blood. 2009;113(16):3781-91.
    • (2009) Blood , vol.113 , Issue.16 , pp. 3781-3791
    • Ocio, E.M.1    Maiso, P.2    Chen, X.3    Garayoa, M.4    Alvarez-Fernandez, S.5    San-Segundo, L.6
  • 12
    • 79954445562 scopus 로고    scopus 로고
    • Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma
    • Paiva B, Perez-Andres M, Vidriales MB, Almeida J, de las Heras N, Mateos MV, et al. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma. Leukemia. 2011;25(4):697-706.
    • (2011) Leukemia , vol.25 , Issue.4 , pp. 697-706
    • Paiva, B.1    Perez-Andres, M.2    Vidriales, M.B.3    Almeida, J.4    de las Heras, N.5    Mateos, M.V.6
  • 13
    • 9144265458 scopus 로고    scopus 로고
    • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
    • van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17(12):2257-317.
    • (2003) Leukemia , vol.17 , Issue.12 , pp. 2257-2317
    • van Dongen, J.J.1    Langerak, A.W.2    Bruggemann, M.3    Evans, P.A.4    Hummel, M.5    Lavender, F.L.6
  • 14
    • 20144367446 scopus 로고    scopus 로고
    • Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia
    • Gutierrez NC, Lopez-Perez R, Hernandez JM, Isidro I, Gonzalez B, Delgado M, et al. Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia. Leukemia. 2005;19(3):402-9.
    • (2005) Leukemia , vol.19 , Issue.3 , pp. 402-409
    • Gutierrez, N.C.1    Lopez-Perez, R.2    Hernandez, J.M.3    Isidro, I.4    Gonzalez, B.5    Delgado, M.6
  • 15
    • 0032821233 scopus 로고    scopus 로고
    • Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation
    • Rottenburger C, Kiel K, Bosing T, Cremer FW, Moldenhauer G, Ho AD, et al. Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation. Br J Haematol. 1999;106(2):545-52.
    • (1999) Br J Haematol , vol.106 , Issue.2 , pp. 545-552
    • Rottenburger, C.1    Kiel, K.2    Bosing, T.3    Cremer, F.W.4    Moldenhauer, G.5    Ho, A.D.6
  • 16
    • 40849151008 scopus 로고    scopus 로고
    • Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
    • Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93(3):431-8.
    • (2008) Haematologica , vol.93 , Issue.3 , pp. 431-438
    • Rawstron, A.C.1    Orfao, A.2    Beksac, M.3    Bezdickova, L.4    Brooimans, R.A.5    Bumbea, H.6
  • 17
    • 77957366599 scopus 로고    scopus 로고
    • A bispecific antibody-IFNalpha2b immunocytokine targeting CD20 and HLA-DR is highly toxic to human lymphoma and multiple myeloma cells
    • Rossi EA, Rossi DL, Stein R, Goldenberg DM, Chang CH. A bispecific antibody-IFNalpha2b immunocytokine targeting CD20 and HLA-DR is highly toxic to human lymphoma and multiple myeloma cells. Cancer Res. 2010;70(19):7600-9.
    • (2010) Cancer Res , vol.70 , Issue.19 , pp. 7600-7609
    • Rossi, E.A.1    Rossi, D.L.2    Stein, R.3    Goldenberg, D.M.4    Chang, C.H.5
  • 19
    • 77958584577 scopus 로고    scopus 로고
    • Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms
    • pii
    • Brennan SK, Wang Q, Tressler R, Harley C, Go N, Bassett E, et al. Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms. PLoS One. 2010; 5(9). pii: e12487.
    • (2010) PLoS One , vol.5 , Issue.9
    • Brennan, S.K.1    Wang, Q.2    Tressler, R.3    Harley, C.4    Go, N.5    Bassett, E.6
  • 21
    • 79955974540 scopus 로고    scopus 로고
    • Lenalidomide targets clonogenic side population in multiple myeloma: Pathophysiologic and clinical implications
    • Jakubikova J, Adamia S, Kost-Alimova M, Klippel S, Cervi D, Daley JF, et al. Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood. 2011;117(17):4409-19.
    • (2011) Blood , vol.117 , Issue.17 , pp. 4409-4419
    • Jakubikova, J.1    Adamia, S.2    Kost-Alimova, M.3    Klippel, S.4    Cervi, D.5    Daley, J.F.6
  • 22
    • 28444485327 scopus 로고    scopus 로고
    • Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies
    • Zweidler-McKay PA, He Y, Xu L, Rodriguez CG, Karnell FG, Carpenter AC, et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood. 2005;106(12):3898-906.
    • (2005) Blood , vol.106 , Issue.12 , pp. 3898-3906
    • Zweidler-McKay, P.A.1    He, Y.2    Xu, L.3    Rodriguez, C.G.4    Karnell, F.G.5    Carpenter, A.C.6
  • 23
    • 79956003265 scopus 로고    scopus 로고
    • Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy
    • Pan Y, Gao Y, Chen L, Gao G, Dong H, Yang Y, et al. Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Clin Cancer Res. 2011;17(10):3248-58.
    • (2011) Clin Cancer Res , vol.17 , Issue.10 , pp. 3248-3258
    • Pan, Y.1    Gao, Y.2    Chen, L.3    Gao, G.4    Dong, H.5    Yang, Y.6
  • 24
    • 0029950423 scopus 로고    scopus 로고
    • Human stem cell assays in immunedeficient mice
    • Dick JE. Human stem cell assays in immunedeficient mice. Curr Opin Hematol. 1996;3 (6):405-9.
    • (1996) Curr Opin Hematol , vol.3 , Issue.6 , pp. 405-409
    • Dick, J.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.